Clinical trial
Mean Platelet Volume (MPV) as an Early Predictor of Mortality in Intensive Care Patients With Cancer
NCT07656311 is registered in ClinicalTrials.gov with Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mean Platelet Volume (MPV) as an Early Predictor of Mortality in Intensive Care Patients With Cancer
- Lead sponsor
- Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 15, 2026
- Completion date
- August 1, 2026
- Enrollment
- 425 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cancer, critical illness, mortality